AbbVie Inc.
ABBV · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $410,289 | $328,919 | $370,431 | $314,351 |
| - Cash | $5,629 | $6,467 | $5,175 | $5,524 |
| + Debt | $68,743 | $70,481 | $69,889 | $67,841 |
| Enterprise Value | $473,403 | $392,933 | $435,145 | $376,668 |
| Revenue | $15,776 | $15,423 | $13,343 | $15,102 |
| % Growth | 2.3% | 15.6% | -11.6% | – |
| Gross Profit | $12,386 | $13,020 | $9,341 | $10,706 |
| % Margin | 78.5% | 84.4% | 70% | 70.9% |
| EBITDA | $3,444 | $4,344 | $4,400 | $535 |
| % Margin | 21.8% | 28.2% | 33% | 3.5% |
| Net Income | $186 | $944 | $1,286 | -$22 |
| % Margin | 1.2% | 6.1% | 9.6% | -0.1% |
| EPS Diluted | 0.1 | 0.53 | 0.72 | -0.018 |
| % Growth | -81.1% | -26.4% | 4,077.9% | – |
| Operating Cash Flow | $7,024 | $5,153 | $1,635 | $7,048 |
| Capital Expenditures | $504 | -$269 | -$235 | -$291 |
| Free Cash Flow | $7,528 | $4,884 | $1,400 | $6,757 |